Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02280785
Brief Title: Brentuximab Vedotin for Relapsed/Refractory CD30-positive Non-Hodgkin Lymphomas (BRAN)

First Submitted : October 5, 2014
First Submitted that Met QC Criteria : October 31, 2014
First Posted : November 3, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : September 4, 2018
Last Update Posted : September 6, 2018